InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

Current share price for AFP : $4.100 0.1 (2.50%)+

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$430 2017 Annual Meeting Results 4 Aug 2017 2:50PM $2.210 $4.100 risen by 85.52%
$430 2017 Annual Meeting presentation 4 Aug 2017 8:45AM $2.210 $4.100 risen by 85.52%
$430 2017 annual meeting - chairman speech 4 Aug 2017 8:45AM $2.210 $4.100 risen by 85.52%
$430 Maxigesic now licensed in 124 countries 20 Jul 2017 9:14AM $2.210 $4.100 risen by 85.52%
$430 AFT Sample proxy 2017 meeting 11 Jul 2017 7:50AM $2.110 $4.100 risen by 94.31%
$430 AFP Notice of Annual Meeting of Shareholders 2017 11 Jul 2017 7:49AM $2.110 $4.100 risen by 94.31%
$430 disclosure notice 7 Jul 2017 11:01AM $2.210 $4.100 risen by 85.52%
$430 disclosure notice 19 Jun 2017 8:25AM $2.610 $4.100 risen by 57.09%
$430 disclosure notice 19 Jun 2017 8:25AM $2.610 $4.100 risen by 57.09%
$430 disclosure notice 19 Jun 2017 8:25AM $2.610 $4.100 risen by 57.09%
$430 disclosure notice 19 Jun 2017 8:24AM $2.610 $4.100 risen by 57.09%
$430 disclosure notice 19 Jun 2017 8:24AM $2.610 $4.100 risen by 57.09%
$430 Appendix 3B - Security Purchase Plan 15 Jun 2017 3:02PM $2.610 $4.100 risen by 57.09%
$430 Successful share purchase plan for AFT Pharmaceuticals 14 Jun 2017 2:25PM $2.610 $4.100 risen by 57.09%
$430 form 209 13 Jun 2017 3:45PM $2.610 $4.100 risen by 57.09%
$430 Annual Report to shareholders 13 Jun 2017 7:30AM $2.610 $4.100 risen by 57.09%
$430 Annual Meeting and Closing Date for Director Nominations 1 Jun 2017 12:11AM $2.600 $4.100 risen by 57.69%
$430 Security Purchase Plan 24 May 2017 7:33AM $2.600 $4.100 risen by 57.69%
$430 Security Purchase Plan 24 May 2017 7:33AM $2.600 $4.100 risen by 57.69%
$430 Security Purchase Plan 24 May 2017 7:33AM $2.600 $4.100 risen by 57.69%
$430 Security Purchase Plan 24 May 2017 7:33AM $2.600 $4.100 risen by 57.69%
$430 Security Purchase Plan 24 May 2017 7:33AM $2.600 $4.100 risen by 57.69%
$430 AFT Pharmaceuticals Presentation FY2017 Full Year Update 24 May 2017 7:32AM $2.600 $4.100 risen by 57.69%
$430 2017 Financial Statements 24 May 2017 7:32AM $2.600 $4.100 risen by 57.69%
$430 Full Year Announcement App I 24 May 2017 7:31AM $2.600 $4.100 risen by 57.69%

376 - 400 of 546 results

Page 16 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.